Abstract:e24125 Background: Recently, there has been a growing interest in lung cancer immunotherapy due to its preliminary results in achieving meaningful treatments responses. We conducted this research for more understanding the immunophenotyping profile of peripheral blood from patients with advanced non-small cell lung cancer (NSCLC) after chemotherapy and the correlation with patients’ survival. Methods: Peripheral blood samples were collected from 15 healthy donors and 35 patients with advanced NSCLC after two cycles of chemotherapy. Phenotypic analysis of lymphocyte subsets (absolute numbers and frequencies) was performed one week after two cycles chemotherapy. The correlation between post-chemotherapy levels of lymphocyte subsets and patients’ progression free survival (PFS) was estimated by a Kaplan–Meier method. Results: After chemotherapy, there was no significant difference in the frequency of CD8+ T lymphocytes, PD-1+CD8+, Th2 and Th17 cells between patients and healthy subjects. The frequencies of PD-1+CD4+ and Treg cells were elevated in patients’ peripheral blood compared to healthy donors, in contrast to the frequencies of NK and Th1 cells. PFS was significantly better in patients with low percentage of PD-1+CD4+T cells than those with high percentage (8.1 months vs. 5.2 months, P = 0.02). Pateints with high content of Th1 cells showed higher PFS than those with low content (9.1 months vs. 5.6 months, P = 0.04). Even though the difference did not reach statistical significance, the low percentages of Th17 and Treg cells were correlated with longer PFS (9.2 months vs. 6.3, P = 0.15 and 9.1 months vs. 6.1 months, P = 0.17; respectively). There was no significant correlation between patients’ PFS and the levels of CD8+ T lymphocytes, PD-1+CD8+, NK and Th2 cells. Conclusions: The expression of PD-1 on CD4+ T cells has a crucial role in the progression of NSCLC and could be used as a prognostic factor. The high level of Th1 cells could predict better clinical outcomes of chemotherapy. Further studies are needed to elucidate the exact function of Th17 cells due to their bi-dual role. CD8+ T, NK, Th2 cells in patients’ peripheral blood have no direct correlation with clinical outcomes.

Impact of Chemotherapy on Peripheral Th1 and Th2 Cytokines Gene Expression in Patients with Breast Cancer

Gene Expressions of Th1 and Th2 Cytokines in Peripheral Blood of Patients with Lung Carcinoma and Relationship Between Their Expression and Chemotherapy

Influence and significance of chemotherapy to the gene expression of Th1 and Th2 cytokines in colon carcinoma

[Influence of Chemotherapy on Th1/Th2 Cytokine Switching in Stomach Cancer Patients].

Influence of Neoadjuvant Chemotherapy on the Expression of Drug Resistance Genes in Breast Carcinoma

Analysis of NK/T and Treg cell in peripheral blood of patients with different malignancies during the chemotherapy

Gene expressions of Th1 and Th2 cytokines in PBMC from patients with gastric carcinoma and their clinical significace

P1.03-046 A Retrospective Analysis of Correlation Between Cytokines in TME and Therapeutic Effect of Advanced Lung Cancer Chemotherapy in China

RESEARCH ON EFFECT OF CHEMOTHERAPY ON CELLULAR IMMUNITY OF PATIENTS WITH LUNG CANCER

The Impact of Chemotherapy on the Immunophenotype of Peripheral Blood Lymphocytes and Survival in Patients with Non-Small Cell Lung Cancer.

Expression status of immune related cytokines mRNA in local microenvironment of breast cancer and its clinicopathologic significance

The Influence of Thymosin Combined with Chemotherapy for Patients with Gastric Cancer on Serum Th1 and Th2 Cytokines

Effect of neoadjuvant chemotherapy on regulatory T cells in the peripheral blood of patients with breast cancer

The Changes of CD4~+ CD25~+ Regulatory T Cells and Cytotoxic T Cell in Patients with Colon Cancer Treated by Chemotherapy or Thermochemotherapy

Influence of Intravenous Chemotherapy on Cytokine in Peripheral Blood Plasma in Patients with Advanced Digestive Tract Cancer

Changes of immune pattern in lung cancer patients before and after chemotherapy

Influence of Chemotherapy on Lymphocyte Subsets in Patients with Advanced Non-Small Cell Lung Cancer

Effects of chemotherapy on humoral immunity of patients with cancer

Impacts of Estrogen Receptor,Progesterone Receptor and Human Epidermal Growth Factor Receptor-2 Status on Chemotherapy Effects in Breast Cancer

The Expression Level Of Brca2 And Its Changes During Chemotherapy In Patients With Different Pathological Types Of Mammary Cancer

Changes in T-lymphocytes in Lung Cancer Patients after Hyperthermic Intraperitoneal Chemotherapy or Radiotherapy.